Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Jan;8(1):131–145. doi: 10.1128/cmr.8.1.131

Viruses, schizophrenia, and bipolar disorder.

R H Yolken 1, E F Torrey 1
PMCID: PMC172852  PMID: 7704891

Abstract

The hypothesis that viruses or other infectious agents may cause schizophrenia or bipolar disorder dates to the 19th century but has recently been revived. It could explain many clinical, genetic, and epidemiologic aspects of these diseases, including the winter-spring birth seasonality, regional differences, urban birth, household crowding, having an older sibling, and prenatal exposure to influenza as risk factors. It could also explain observed immunological changes such as abnormalities of lymphocytes, proteins, autoantibodies, and cytokines. However, direct studies of viral infections in individuals with these psychiatric diseases have been predominantly negative. Most studies have examined antibodies in blood or cerebrospinal fluid, and relatively few studies have been done on viral antigens, genomes, cytopathic effect on cell culture, and animal transmission experiments. Viral research on schizophrenia and bipolar disorder is thus comparable to viral research on multiple sclerosis and Parkinson's disease: an attractive hypothesis with scattered interesting findings but no clear proof. The application of molecular biological techniques may allow the identification of novel infectious agents and the associations of these novel agents with serious mental diseases.

Full Text

The Full Text of this article is available as a PDF (257.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahokas A., Koskiniemi M. L., Vaheri A., Rimón R. Altered white cell count, protein concentration and oligoclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders. Neuropsychobiology. 1985;14(1):1–4. doi: 10.1159/000118192. [DOI] [PubMed] [Google Scholar]
  2. Ahokas A., Rimón R., Koskiniemi M., Vaheri A., Julkunen I., Sarna S. Viral antibodies and interferon in acute psychiatric disorders. J Clin Psychiatry. 1987 May;48(5):194–196. [PubMed] [Google Scholar]
  3. Albrecht P., Torrey E. F., Boone E., Hicks J. T., Daniel N. Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet. 1980 Oct 11;2(8198):769–772. doi: 10.1016/s0140-6736(80)90386-4. [DOI] [PubMed] [Google Scholar]
  4. Alexander R. C., Cabirac G., Lowenkopf T., Casanova M., Kleinman J., Wyatt R. J., Kirch D. G. Search for evidence of herpes simplex virus, type 1, or varicella-zoster virus infection in postmortem brain tissue from schizophrenic patients. Acta Psychiatr Scand. 1992 Nov;86(5):418–420. doi: 10.1111/j.1600-0447.1992.tb03290.x. [DOI] [PubMed] [Google Scholar]
  5. Alexander R. C., Spector S. A., Casanova M., Kleinman J., Wyatt R. J., Kirch D. G. Search for cytomegalovirus in the postmortem brains of schizophrenic patients using the polymerase chain reaction. Arch Gen Psychiatry. 1992 Jan;49(1):47–53. doi: 10.1001/archpsyc.1992.01820010047006. [DOI] [PubMed] [Google Scholar]
  6. Amsterdam J. D., Maislin G., Rybakowski J. A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biol Psychiatry. 1990 Feb 15;27(4):447–453. doi: 10.1016/0006-3223(90)90555-g. [DOI] [PubMed] [Google Scholar]
  7. Amsterdam J. D., Winokur A., Dyson W., Herzog S., Gonzalez F., Rott R., Koprowski H. Borna disease virus. A possible etiologic factor in human affective disorders? Arch Gen Psychiatry. 1985 Nov;42(11):1093–1096. doi: 10.1001/archpsyc.1985.01790340077011. [DOI] [PubMed] [Google Scholar]
  8. Arima T., Shimomura H., Nakajima T., Kanai K., Nagashima H., Tsuji T. Cloning of hepatitis C virus genomes and their properties. Gastroenterol Jpn. 1990 Sep;25 (Suppl 2):72–76. doi: 10.1007/BF02779932. [DOI] [PubMed] [Google Scholar]
  9. Aulakh G. S., Kleinman J. E., Aulakh H. S., Albrecht P., Torrey E. F., Wyatt R. J. Search for cytomegalovirus in schizophrenic brain tissue. Proc Soc Exp Biol Med. 1981 Jun;167(2):172–174. doi: 10.3181/00379727-167-41144. [DOI] [PubMed] [Google Scholar]
  10. Axelsson R., Martensson E., Alling C. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry. 1982 Sep;141:273–281. doi: 10.1192/bjp.141.3.273. [DOI] [PubMed] [Google Scholar]
  11. Baker H. F., Ridley R. M., Crow T. J., Bloxham C. A., Parry R. P., Tyrrell D. A. An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease. Psychol Med. 1983 Aug;13(3):499–511. doi: 10.1017/s0033291700047930. [DOI] [PubMed] [Google Scholar]
  12. Baker H. F., Ridley R. M., Crow T. J., Tyrrell D. A. A re-investigation of the behavioural effects of intracerebral injection in marmosets of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease. Psychol Med. 1989 May;19(2):325–329. doi: 10.1017/s0033291700012368. [DOI] [PubMed] [Google Scholar]
  13. Baron M., Stern M., Anavi R., Witz I. P. Tissue-binding factor in schizophrenic sera: a clinical and genetic study. Biol Psychiatry. 1977 Apr;12(2):199–219. [PubMed] [Google Scholar]
  14. Barr C. E., Mednick S. A., Munk-Jorgensen P. Exposure to influenza epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry. 1990 Sep;47(9):869–874. doi: 10.1001/archpsyc.1990.01810210077012. [DOI] [PubMed] [Google Scholar]
  15. Bauer K., Kornhuber J. Blood-cerebrospinal fluid barrier in schizophrenic patients. Eur Arch Psychiatry Neurol Sci. 1987;236(5):257–259. doi: 10.1007/BF00380949. [DOI] [PubMed] [Google Scholar]
  16. Becker D., Kritschmann E., Floru S., Shlomo-David Y., Gotlieb-Stematsky T. Serum interferon in first psychotic attack. Br J Psychiatry. 1990 Jul;157:136–138. doi: 10.1192/bjp.157.1.136. [DOI] [PubMed] [Google Scholar]
  17. Boyd J. H., Pulver A. E., Stewart W. Season of birth: schizophrenia and bipolar disorder. Schizophr Bull. 1986;12(2):173–186. doi: 10.1093/schbul/12.2.173. [DOI] [PubMed] [Google Scholar]
  18. Bracha H. S., Torrey E. F., Gottesman I. I., Bigelow L. B., Cunniff C. Second-trimester markers of fetal size in schizophrenia: a study of monozygotic twins. Am J Psychiatry. 1992 Oct;149(10):1355–1361. doi: 10.1176/ajp.149.10.1355. [DOI] [PubMed] [Google Scholar]
  19. Bradbury T. N., Miller G. A. Season of birth in schizophrenia: a review of evidence, methodology, and etiology. Psychol Bull. 1985 Nov;98(3):569–594. [PubMed] [Google Scholar]
  20. Brookes S. M., Pandolfino Y. A., Mitchell T. J., Venables P. J., Shattles W. G., Clark D. A., Entwistle A., Maini R. N. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol. 1992 Nov;31(11):735–742. doi: 10.1093/rheumatology/31.11.735. [DOI] [PubMed] [Google Scholar]
  21. Bártová L., Rajcáni J., Pogády J. Herpes simplex virus antibodies in the cerebrospinal fluid of schizophrenic patients. Acta Virol. 1987 Sep;31(5):443–446. [PubMed] [Google Scholar]
  22. Bök J. A., Wetterberg L., Modrzewska K. Schizophrenia in a North Swedish geographical isolate, 1900--1977. Epidemiology, genetics and biochemistry. Clin Genet. 1978 Dec;14(6):373–394. doi: 10.1111/j.1399-0004.1978.tb02105.x. [DOI] [PubMed] [Google Scholar]
  23. Cappel R., Gregoire F., Thiry L., Sprecher S. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. J Clin Psychiatry. 1978 Mar;39(3):266–268. [PubMed] [Google Scholar]
  24. Carter G. I., Taylor G. R., Crow T. J. Search for viral nucleic acid sequences in the post mortem brains of patients with schizophrenia and individuals who have committed suicide. J Neurol Neurosurg Psychiatry. 1987 Mar;50(3):247–251. doi: 10.1136/jnnp.50.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Chacon C., Monro M., Harper I. Viral infection and psychiatric disorders. Acta Psychiatr Scand. 1975 Feb;51(2):101–103. doi: 10.1111/j.1600-0447.1975.tb00218.x. [DOI] [PubMed] [Google Scholar]
  26. Chang T. W. Letter: Suppression of herpetic recurrence by chlorpromazine. N Engl J Med. 1975 Jul 17;293(3):153–154. [PubMed] [Google Scholar]
  27. Coffey C. E., Sullivan J. L., Rice J. R. T lymphocytes in schizophrenia. Biol Psychiatry. 1983 Jan;18(1):113–119. [PubMed] [Google Scholar]
  28. Coggiano M. A., Alexander R. C., Kirch D. G., Wyatt R. J., Kulaga H. The continued search for evidence of retroviral infection in schizophrenic patients. Schizophr Res. 1991 Oct;5(3):243–247. doi: 10.1016/0920-9964(91)90082-3. [DOI] [PubMed] [Google Scholar]
  29. Cooper S. J., Best S., King D. J. Can psychiatric nurses 'catch' schizophrenia? Br J Psychiatry. 1987 Oct;151:546–548. doi: 10.1192/bjp.151.4.546. [DOI] [PubMed] [Google Scholar]
  30. Crocetti G. M., Lemkau P. V., Kulcar Z., Kesić B. Selected aspects of the epidemiology of psychoses in Croatia, Yugoslavia. 3. The cluster sample and the results of the pilot survey. Am J Epidemiol. 1971 Aug;94(2):126–134. doi: 10.1093/oxfordjournals.aje.a121304. [DOI] [PubMed] [Google Scholar]
  31. Crow T. J., Done D. J. Age of onset of schizophrenia in siblings: a test of the contagion hypothesis. Psychiatry Res. 1986 Jun;18(2):107–117. doi: 10.1016/0165-1781(86)90023-5. [DOI] [PubMed] [Google Scholar]
  32. Crow T. J., Done D. J. Prenatal exposure to influenza does not cause schizophrenia. Br J Psychiatry. 1992 Sep;161:390–393. doi: 10.1192/bjp.161.3.390. [DOI] [PubMed] [Google Scholar]
  33. DeLisi L. E., King A. C., Targum S. Serum immunoglobulin concentrations in patients admitted to an acute psychiatric in-patient service. Br J Psychiatry. 1984 Dec;145:661–665. doi: 10.1192/bjp.145.6.661. [DOI] [PubMed] [Google Scholar]
  34. DeLisi L. E., Sarin P. S. Lack of evidence for retrovirus infection in schizophrenic patients. Br J Psychiatry. 1985 Jun;146:674–675. [PubMed] [Google Scholar]
  35. Delisi L. E., Smith S. B., Hamovit J. R., Maxwell M. E., Goldin L. R., Dingman C. W., Gershon E. S. Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychol Med. 1986 Nov;16(4):757–763. doi: 10.1017/s0033291700011764. [DOI] [PubMed] [Google Scholar]
  36. Delisi L. E., Weinberger D. R., Potkin S., Neckers L. M., Shiling D. J., Wyatt R. J. Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br J Psychiatry. 1981 Dec;139:513–518. doi: 10.1192/bjp.139.6.513. [DOI] [PubMed] [Google Scholar]
  37. Duguid J. R., Dinauer M. C. Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in scrapie infection. Nucleic Acids Res. 1990 May 11;18(9):2789–2792. doi: 10.1093/nar/18.9.2789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Dvoráková M., Zvolský P., Jandová A. LDH virus a zmeny celulární imunity u schizofreniků a jejich príbuzných. Sb Lek. 1990 Oct;92(10):305–310. [PubMed] [Google Scholar]
  39. FESSEL W. J., HIRATA-HIBI M. ABNORMAL LEUKOCYTES IN SCHIZOPHRENIA. Arch Gen Psychiatry. 1963 Dec;9:601–613. doi: 10.1001/archpsyc.1963.01720180073010. [DOI] [PubMed] [Google Scholar]
  40. Feenstra A., Kirch D. G., Bracha H. S., Wyatt R. J. Lack of evidence for a role of T-cell-associated retroviruses as an etiology of schizophrenia. Biol Psychiatry. 1989 Feb 15;25(4):421–430. doi: 10.1016/0006-3223(89)90195-9. [DOI] [PubMed] [Google Scholar]
  41. Feenstra A., Kirch D. G., Coggiano M. A., Wyatt R. J. Reverse transcriptase activity in 5-azacytidine-treated lymphocyte cultures of patients with schizophrenia. Schizophr Res. 1988 Nov-Dec;1(6):385–389. doi: 10.1016/0920-9964(88)90019-9. [DOI] [PubMed] [Google Scholar]
  42. Fieve R. R., Blumenthal B., Little B. The relationship of atypical lymphocytes, phenothiazines, and schizophrenia. Arch Gen Psychiatry. 1966 Nov;15(5):529–534. doi: 10.1001/archpsyc.1966.01730170081012. [DOI] [PubMed] [Google Scholar]
  43. Fish B., Marcus J., Hans S. L., Auerbach J. G., Perdue S. Infants at risk for schizophrenia: sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry. 1992 Mar;49(3):221–235. doi: 10.1001/archpsyc.1992.01820030053007. [DOI] [PubMed] [Google Scholar]
  44. Fossan G. O., Larsen J. L. Variation of immunoglobulin G and total protein concentrations during lumbar cerebrospinal fluid collection. Eur Neurol. 1979;18(2):140–144. doi: 10.1159/000115069. [DOI] [PubMed] [Google Scholar]
  45. Fux M., Sarov I., Ginot Y., Sarov B. Herpes simplex virus and cytomegalovirus in the serum of schizophrenic patients versus other psychosis and normal controls. Isr J Psychiatry Relat Sci. 1992;29(1):33–35. [PubMed] [Google Scholar]
  46. Gajdusek D. C., Gibbs C. J., Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature. 1966 Feb 19;209(5025):794–796. doi: 10.1038/209794a0. [DOI] [PubMed] [Google Scholar]
  47. Ganguli R., Brar J. S., Solomon W., Chengappa K. N., Rabin B. S. Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatry Res. 1992 Nov;44(2):113–123. doi: 10.1016/0165-1781(92)90046-6. [DOI] [PubMed] [Google Scholar]
  48. Ganguli R., Rabin B. S. CD5 positive B lymphocytes in schizophrenia: no alteration in numbers or percentage as compared with control subjects. Psychiatry Res. 1993 Jul;48(1):69–78. doi: 10.1016/0165-1781(93)90114-v. [DOI] [PubMed] [Google Scholar]
  49. Ganguli R., Rabin B. S. Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. Arch Gen Psychiatry. 1989 Mar;46(3):292–292. doi: 10.1001/archpsyc.1989.01810030098018. [DOI] [PubMed] [Google Scholar]
  50. Gattaz W. F., Dalgalarrondo P., Schröder H. C. Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. Schizophr Res. 1992 Mar;6(3):237–241. doi: 10.1016/0920-9964(92)90006-q. [DOI] [PubMed] [Google Scholar]
  51. Gibbs C. J., Jr, Gajdusek D. C., Asher D. M., Alpers M. P., Beck E., Daniel P. M., Matthews W. B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science. 1968 Jul 26;161(3839):388–389. doi: 10.1126/science.161.3839.388. [DOI] [PubMed] [Google Scholar]
  52. Gotlieb-Stematsky T., Zonis J., Arlazoroff A., Mozes T., Sigal M., Szekely A. G. Antibodies to Epstein-Barr virus, herpes simplex type 1, cytomegalovirus and measles virus in psychiatric patients. Arch Virol. 1981;67(4):333–339. doi: 10.1007/BF01314836. [DOI] [PubMed] [Google Scholar]
  53. Green M. F., Satz P., Gaier D. J., Ganzell S., Kharabi F. Minor physical anomalies in schizophrenia. Schizophr Bull. 1989;15(1):91–99. doi: 10.1093/schbul/15.1.91. [DOI] [PubMed] [Google Scholar]
  54. Gualtieri C. T., Adams A., Shen C. D., Loiselle D. Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children. Am J Psychiatry. 1982 May;139(5):640–643. doi: 10.1176/ajp.139.5.640. [DOI] [PubMed] [Google Scholar]
  55. Guy J. D., Majorski L. V., Wallace C. J., Guy M. P. The incidence of minor physical anomalies in adult male schizophrenics. Schizophr Bull. 1983;9(4):571–582. doi: 10.1093/schbul/9.4.571. [DOI] [PubMed] [Google Scholar]
  56. HIRATA-HIBI M., FESSEL W. J. THE BONE MARROW IN SCHIZOPHRENIA. Arch Gen Psychiatry. 1964 Apr;10:414–419. doi: 10.1001/archpsyc.1964.01720220092014. [DOI] [PubMed] [Google Scholar]
  57. Halonen P. E., Rimon R., Arohonka K., Jäntti V. Antibody levels to herpes simplex type I, measles and rubella viruses in psychiatric patients. Br J Psychiatry. 1974 Nov;125:461–465. doi: 10.1192/bjp.125.5.461. [DOI] [PubMed] [Google Scholar]
  58. Harrington M. G., Merril C. R., Torrey E. F. Differences in cerebrospinal fluid proteins between patients with schizophrenia and normal persons. Clin Chem. 1985 May;31(5):722–726. [PubMed] [Google Scholar]
  59. Harrison G., Owens D., Holton A., Neilson D., Boot D. A prospective study of severe mental disorder in Afro-Caribbean patients. Psychol Med. 1988 Aug;18(3):643–657. doi: 10.1017/s0033291700008321. [DOI] [PubMed] [Google Scholar]
  60. Heath R. G., Krupp I. M. Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gen Psychiatry. 1967 Jan;16(1):1–9. doi: 10.1001/archpsyc.1967.01730190003001. [DOI] [PubMed] [Google Scholar]
  61. Heinrichs D. W., Buchanan R. W. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988 Jan;145(1):11–18. doi: 10.1176/ajp.145.1.11. [DOI] [PubMed] [Google Scholar]
  62. Henneberg A. E., Ruffert S., Henneberg H. J., Kornhuber H. H. Antibodies to brain tissue in sera of schizophrenic patients--preliminary findings. Eur Arch Psychiatry Clin Neurosci. 1993;242(5):314–317. doi: 10.1007/BF02190392. [DOI] [PubMed] [Google Scholar]
  63. Hirata-Hibi M., Hayashi K. The anatomy of the P lymphocyte. Schizophr Res. 1993 Jan;8(3):257–262. doi: 10.1016/0920-9964(93)90024-d. [DOI] [PubMed] [Google Scholar]
  64. Hirata-Hibi M., Higashi S., Tachibana T., Watanabe N. Stimulated lymphocytes in schizophrenia. Arch Gen Psychiatry. 1982 Jan;39(1):82–87. doi: 10.1001/archpsyc.1982.04290010058011. [DOI] [PubMed] [Google Scholar]
  65. Hunter R., Jones M., Malleson A. Abnormal cerebrospinal fluid total protein and gamma-blobulin levels in 256 patients admitted to a psychiatric unit. J Neurol Sci. 1969 Jul-Aug;9(1):11–38. doi: 10.1016/0022-510x(69)90056-2. [DOI] [PubMed] [Google Scholar]
  66. Iwasaki Y. Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathol. 1993 Jan;3(1):1–10. doi: 10.1111/j.1750-3639.1993.tb00719.x. [DOI] [PubMed] [Google Scholar]
  67. Jiang X., Wang M., Wang K., Estes M. K. Sequence and genomic organization of Norwalk virus. Virology. 1993 Jul;195(1):51–61. doi: 10.1006/viro.1993.1345. [DOI] [PubMed] [Google Scholar]
  68. Johnson G., Brane D., Block W., van Kammen D. P., Gurklis J., Peters J. L., Wyatt R. J., Kirch D. G., Ghanbari H. A., Merril C. R. Cerebrospinal fluid protein variations in common to Alzheimer's disease and schizophrenia. Appl Theor Electrophor. 1992;3(2):47–53. [PubMed] [Google Scholar]
  69. Jones P. Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch Gen Psychiatry. 1994 Apr;51(4):333–334. doi: 10.1001/archpsyc.1994.03950040077010. [DOI] [PubMed] [Google Scholar]
  70. Kaufmann C. A., Weinberger D. R., Stevens J. R., Asher D. M., Kleinman J. E., Sulima M. P., Gibbs C. J., Jr, Gajdusek D. C. Intracerebral inoculation of experimental animals with brain tissue from patients with schizophrenia. Failure to observe consistent or specific behavioral and neuropathological effects. Arch Gen Psychiatry. 1988 Jul;45(7):648–652. doi: 10.1001/archpsyc.1988.01800310056007. [DOI] [PubMed] [Google Scholar]
  71. Kaufmann C. A., Weinberger D. R., Yolken R. H., Torrey E. F., Pofkin S. G. Viruses and schizophrenia. Lancet. 1983 Nov 12;2(8359):1136–1137. doi: 10.1016/s0140-6736(83)90645-1. [DOI] [PubMed] [Google Scholar]
  72. Kelly R. H., Ganguli R., Rabin B. S. Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia. Biol Psychiatry. 1987 Dec;22(12):1488–1491. doi: 10.1016/0006-3223(87)90110-7. [DOI] [PubMed] [Google Scholar]
  73. Kendell R. E., Kemp I. W. Maternal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 1989 Oct;46(10):878–882. doi: 10.1001/archpsyc.1989.01810100020004. [DOI] [PubMed] [Google Scholar]
  74. Kilidireas K., Latov N., Strauss D. H., Gorig A. D., Hashim G. A., Gorman J. M., Sadiq S. A. Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia. Lancet. 1992 Sep 5;340(8819):569–572. doi: 10.1016/0140-6736(92)92105-o. [DOI] [PubMed] [Google Scholar]
  75. King D. J., Cooper S. J., Earle J. A., Martin S. J., McFerran N. V., Rima B. K., Wisdom G. B. A survey of serum antibodies to eight common viruses in psychiatric patients. Br J Psychiatry. 1985 Aug;147:137–144. doi: 10.1192/bjp.147.2.137. [DOI] [PubMed] [Google Scholar]
  76. King D. J., Cooper S. J., Earle J. A., Martin S. J., McFerran N. V., Wisdom G. B. Serum and CSF antibody titres to seven common viruses in schizophrenic patients. Br J Psychiatry. 1985 Aug;147:145–149. doi: 10.1192/bjp.147.2.145. [DOI] [PubMed] [Google Scholar]
  77. King D. J., Cooper S. J. Viruses, immunity and mental disorder. Br J Psychiatry. 1989 Jan;154:1–7. doi: 10.1192/bjp.154.1.1. [DOI] [PubMed] [Google Scholar]
  78. King D. J., Griffiths K., Reilly P. M., Merrett J. D. Psychotropic drug use in Northern Ireland 1966-80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables. Psychol Med. 1982 Nov;12(4):819–833. doi: 10.1017/s0033291700049126. [DOI] [PubMed] [Google Scholar]
  79. Kirch D. G., Alexander R. C., Suddath R. L., Papadopoulos N. M., Kaufmann C. A., Daniel D. G., Wyatt R. J. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia. J Neural Transm Gen Sect. 1992;89(3):219–232. doi: 10.1007/BF01250674. [DOI] [PubMed] [Google Scholar]
  80. Knight J., Knight A., Ungvari G. Can autoimmune mechanisms account for the genetic predisposition to schizophrenia? Br J Psychiatry. 1992 Apr;160:533–540. doi: 10.1192/bjp.160.4.533. [DOI] [PubMed] [Google Scholar]
  81. Kristiansen J. E., Andersen L. P., Vestergaard B. F., Hvidberg E. F. Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. Pharmacol Toxicol. 1991 May;68(5):399–403. doi: 10.1111/j.1600-0773.1991.tb01260.x. [DOI] [PubMed] [Google Scholar]
  82. Kronfol Z., House J. D. Immune function in mania. Biol Psychiatry. 1988 Jul;24(3):341–343. doi: 10.1016/0006-3223(88)90204-1. [DOI] [PubMed] [Google Scholar]
  83. Kronfol Z., Silva J., Jr, Greden J., Dembinski S., Gardner R., Carroll B. Impaired lymphocyte function in depressive illness. Life Sci. 1983 Jul 18;33(3):241–247. doi: 10.1016/0024-3205(83)90382-x. [DOI] [PubMed] [Google Scholar]
  84. Kunugi H., Nanko S., Takei N. Influenza and schizophrenia in Japan. Br J Psychiatry. 1992 Aug;161:274–275. doi: 10.1192/bjp.161.2.274. [DOI] [PubMed] [Google Scholar]
  85. Legros S., Mendlewicz J., Wybran J. Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci. 1985;235(1):9–11. doi: 10.1007/BF00380962. [DOI] [PubMed] [Google Scholar]
  86. Lewis G., David A., Andréasson S., Allebeck P. Schizophrenia and city life. Lancet. 1992 Jul 18;340(8812):137–140. doi: 10.1016/0140-6736(92)93213-7. [DOI] [PubMed] [Google Scholar]
  87. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14;257(5072):967–971. doi: 10.1126/science.1354393. [DOI] [PubMed] [Google Scholar]
  88. Libìkovà H., Pogády J., Stancek D., Mucha V. Hepatitis B and herpes viral components in the cerebrospinal fluid of chronic schizophrenic and senile demented patients. Acta Virol. 1981 Jul;25(4):182–190. [PubMed] [Google Scholar]
  89. Libíková H., Breier S., Kocisová M., Pogády J., Stünzner D., Ujházyová D. Assay of interferon and viral antibodies in the cerebrospinal fluid in clinical neurology and psychiatry. Acta Biol Med Ger. 1979;38(5-6):879–893. [PubMed] [Google Scholar]
  90. Libíková H., Pogády J., Rajcáni J., Skodácek I., Ciampor F., Kocisová M. Latent herpesvirus hominis 1 in the central nervous system of psychotic patients. Acta Virol. 1979 May;23(3):231–239. [PubMed] [Google Scholar]
  91. Libíkowa H., Stancek D., Wiedermann V., Hasto J., Breier S. Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical study. Arch Immunol Ther Exp (Warsz) 1977;25(5):641–649. [PubMed] [Google Scholar]
  92. Lisitsyn N., Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science. 1993 Feb 12;259(5097):946–951. doi: 10.1126/science.8438152. [DOI] [PubMed] [Google Scholar]
  93. Lohr J. B., Flynn K. Minor physical anomalies in schizophrenia and mood disorders. Schizophr Bull. 1993;19(3):551–556. doi: 10.1093/schbul/19.3.551. [DOI] [PubMed] [Google Scholar]
  94. Lycke E., Norrby R., Roos B. E. A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br J Psychiatry. 1974 Mar;124(0):273–279. doi: 10.1192/bjp.124.3.273. [DOI] [PubMed] [Google Scholar]
  95. MOROZOV V. M. K voprosu o virusnoi etiologii shizofrenii. Zh Nevropatol Psikhiatr Im S S Korsakova. 1954 Sep;54(9):732–735. [PubMed] [Google Scholar]
  96. McAllister C. G., Rapaport M. H., Pickar D., Podruchny T. A., Christison G., Alphs L. D., Paul S. M. Increased numbers of CD5+ B lymphocytes in schizophrenic patients. Arch Gen Psychiatry. 1989 Oct;46(10):890–894. doi: 10.1001/archpsyc.1989.01810100032006. [DOI] [PubMed] [Google Scholar]
  97. Mednick S. A., Machon R. A., Huttunen M. O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry. 1988 Feb;45(2):189–192. doi: 10.1001/archpsyc.1988.01800260109013. [DOI] [PubMed] [Google Scholar]
  98. Mered B., Albrecht P., Torrey E. F., Weinberger D. R., Potkin S. G., Winfrey C. J. Failure to isolate virus from CSF of schizophrenics. Lancet. 1983 Oct 15;2(8355):919–919. doi: 10.1016/s0140-6736(83)90914-5. [DOI] [PubMed] [Google Scholar]
  99. Moises H. W., Rüger R., Reynolds G. P., Fleckenstein B. Human cytomegalovirus DNA in the temporal cortex of a schizophrenic patient. Eur Arch Psychiatry Neurol Sci. 1988;238(2):110–113. doi: 10.1007/BF00452786. [DOI] [PubMed] [Google Scholar]
  100. Moises H. W., Schindler L., Leroux M., Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatr Scand. 1985 Jul;72(1):45–50. doi: 10.1111/j.1600-0447.1985.tb02569.x. [DOI] [PubMed] [Google Scholar]
  101. Müller N., Ackenheil M., Hofschuster E., Mempel W., Eckstein R. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res. 1991 May;37(2):147–160. doi: 10.1016/0165-1781(91)90072-w. [DOI] [PubMed] [Google Scholar]
  102. O'Callaghan E., Sham P., Takei N., Glover G., Murray R. M. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet. 1991 May 25;337(8752):1248–1250. doi: 10.1016/0140-6736(91)92919-s. [DOI] [PubMed] [Google Scholar]
  103. Oldstone M. B., Sinha Y. N., Blount P., Tishon A., Rodriguez M., von Wedel R., Lampert P. W. Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science. 1982 Dec 10;218(4577):1125–1127. doi: 10.1126/science.7146898. [DOI] [PubMed] [Google Scholar]
  104. Pandey R. S., Gupta A. K., Chaturvedi U. C. Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry. 1981 Dec;16(12):1123–1136. [PubMed] [Google Scholar]
  105. Patou G., Crow T. J., Taylor G. R. The effects of psychotropic drugs on synthesis of DNA and the infectivity of herpes simplex virus. Biol Psychiatry. 1986 Oct;21(12):1221–1225. doi: 10.1016/0006-3223(86)90228-3. [DOI] [PubMed] [Google Scholar]
  106. Pelonero A. L., Pandurangi A. K., Calabrese V. P. Autoantibodies to brain lipids in schizophrenia. Am J Psychiatry. 1990 May;147(5):661–662. doi: 10.1176/ajp.147.5.661. [DOI] [PubMed] [Google Scholar]
  107. Pokorny A. D., Rawls W. E., Adam E., Mefferd R. B., Jr Depression, psychopathy, and herpesvirus type I antibodies. Lack of relationship. Arch Gen Psychiatry. 1973 Dec;29(6):820–822. doi: 10.1001/archpsyc.1973.04200060092014. [DOI] [PubMed] [Google Scholar]
  108. Preble O. T., Torrey E. F. Serum interferon in patients with psychosis. Am J Psychiatry. 1985 Oct;142(10):1184–1186. doi: 10.1176/ajp.142.10.1184. [DOI] [PubMed] [Google Scholar]
  109. Rapaport M. H., McAllister C. G., Pickar D., Nelson D. L., Paul S. M. Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch Gen Psychiatry. 1989 Mar;46(3):291–292. doi: 10.1001/archpsyc.1989.01810030097017. [DOI] [PubMed] [Google Scholar]
  110. Rapaport M. H., Torrey E. F., McAllister C. G., Nelson D. L., Pickar D., Paul S. M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur Arch Psychiatry Clin Neurosci. 1993;243(1):7–10. doi: 10.1007/BF02191517. [DOI] [PubMed] [Google Scholar]
  111. Rhodes R. H., Novak R., Beattie J. F., West H. M., Whetsell W. O., Jr Immunoperoxidase demonstration of herpes simplex virus type 1 in the brain of a psychotic patient without history of encephalitis. Clin Neuropathol. 1984 Mar-Apr;3(2):59–67. [PubMed] [Google Scholar]
  112. Rimon R., Halonen P., Anttinen E., Evola K. Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Dis Nerv Syst. 1971 Dec;32(12):822–824. [PubMed] [Google Scholar]
  113. Rimon R., Halonen P. Herpes simplex virus infection and depressive illness. Dis Nerv Syst. 1969 May;30(5):338–340. [PubMed] [Google Scholar]
  114. Rimón R., Ahokas A., Palo J. Serum and cerebrospinal fluid antibodies to cytomegalovirus in schizophrenia. Acta Psychiatr Scand. 1986 Jun;73(6):642–644. doi: 10.1111/j.1600-0447.1986.tb02737.x. [DOI] [PubMed] [Google Scholar]
  115. Rimón R., Nishmi M., Halonen P. Serum and CSF antibody levels to herpes simplex type 1, measles and rubella viruses in patients with schizophrenia. Ann Clin Res. 1978 Oct;10(5):291–293. [PubMed] [Google Scholar]
  116. Robert-Guroff M., Torrey E. F., Brown M. Retroviruses and schizophrenia. Br J Psychiatry. 1985 Mar;146:326–326. doi: 10.1192/bjp.146.3.326b. [DOI] [PubMed] [Google Scholar]
  117. Roos B. E. Schizophrenia and viral and auto immune issues. Psychopharmacol Bull. 1984 Summer;20(3):514–518. [PubMed] [Google Scholar]
  118. Roos R. P., Davis K., Meltzer H. Y. Immunoglobulin studies in patients with psychiatric diseases. Arch Gen Psychiatry. 1985 Feb;42(2):124–128. doi: 10.1001/archpsyc.1985.01790250018002. [DOI] [PubMed] [Google Scholar]
  119. Roos R. P. Genetically controlled resistance to virus infections of the central nervous system. Prog Med Genet. 1985;6:241–276. [PubMed] [Google Scholar]
  120. Roy A., Pickar D., Ninan P., Hooks J., Paul S. M. A search for interferon in the CSF of chronic schizophrenic patients. Am J Psychiatry. 1985 Feb;142(2):269–269. doi: 10.1176/ajp.142.2.269a. [DOI] [PubMed] [Google Scholar]
  121. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  122. Schindler L., Leroux M., Beck J., Moises H. W., Kirchner H. Studies of cellular immunity, serum interferon titers, and natural killer cell activity in schizophrenic patients. Acta Psychiatr Scand. 1986 Jun;73(6):651–657. doi: 10.1111/j.1600-0447.1986.tb02739.x. [DOI] [PubMed] [Google Scholar]
  123. Schweitzer L., Su W. H. Population density and the rate of mental illness. Am J Public Health. 1977 Dec;67(12):1165–1172. doi: 10.2105/ajph.67.12.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Scott J. K., Smith G. P. Searching for peptide ligands with an epitope library. Science. 1990 Jul 27;249(4967):386–390. doi: 10.1126/science.1696028. [DOI] [PubMed] [Google Scholar]
  125. Sequiera L. W., Jennings L. C., Carrasco L. H., Lord M. A., Curry A., Sutton R. N. Detection of herpes-simplex viral genome in brain tissue. Lancet. 1979 Sep 22;2(8143):609–612. doi: 10.1016/s0140-6736(79)91667-2. [DOI] [PubMed] [Google Scholar]
  126. Sham P. C., MacLean C. J., Kendler K. S. Risk of schizophrenia and age difference with older siblings. Evidence for a maternal viral infection hypothesis? Br J Psychiatry. 1993 Nov;163:627–633. doi: 10.1192/bjp.163.5.627. [DOI] [PubMed] [Google Scholar]
  127. Sham P. C., O'Callaghan E., Takei N., Murray G. K., Hare E. H., Murray R. M. Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960. Br J Psychiatry. 1992 Apr;160:461–466. doi: 10.1192/bjp.160.4.461. [DOI] [PubMed] [Google Scholar]
  128. Shirabe S., Stevens J. R., Schwartz J. P. Characterization of a transmissible growth-promoting agent derived from CSF of schizophrenic patients which is active on human neuroblastoma cells. J Neurosci Res. 1993 Apr 15;34(6):622–628. doi: 10.1002/jnr.490340604. [DOI] [PubMed] [Google Scholar]
  129. Shrikhande S., Hirsch S. R., Coleman J. C., Reveley M. A., Dayton R. Cytomegalovirus and schizophrenia. A test of a viral hypothesis. Br J Psychiatry. 1985 May;146:503–506. doi: 10.1192/bjp.146.5.503. [DOI] [PubMed] [Google Scholar]
  130. Stevens J. R., Langloss J. M., Albrecht P., Yolken R., Wang Y. N. A search for cytomegalovirus and herpes viral antigen in brains of schizophrenic patients. Arch Gen Psychiatry. 1984 Aug;41(8):795–801. doi: 10.1001/archpsyc.1984.01790190069009. [DOI] [PubMed] [Google Scholar]
  131. Stevens J. R., Papadopoulos N. M., Resnick M. Oligoclonal bands in acute schizophrenia: a negative search. Acta Psychiatr Scand. 1990 Mar;81(3):262–264. doi: 10.1111/j.1600-0447.1990.tb06493.x. [DOI] [PubMed] [Google Scholar]
  132. Susser E. S., Lin S. P. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry. 1992 Dec;49(12):983–988. doi: 10.1001/archpsyc.1992.01820120071010. [DOI] [PubMed] [Google Scholar]
  133. Susser E., Lin S. P., Brown A. S., Lumey L. H., Erlenmeyer-Kimling L. No relation between risk of schizophrenia and prenatal exposure to influenza in Holland. Am J Psychiatry. 1994 Jun;151(6):922–924. doi: 10.1176/ajp.151.6.922. [DOI] [PubMed] [Google Scholar]
  134. Takei N., Sham P. C., O'Callaghan E., Murray R. M. Cities, winter birth, and schizophrenia. Lancet. 1992 Aug 29;340(8818):558–559. doi: 10.1016/0140-6736(92)91762-w. [DOI] [PubMed] [Google Scholar]
  135. Taylor G. R., Crow T. J., Higgins T., Reynolds G. Search for cytomegalovirus in postmortem brain tissue from patients with Huntington's chorea and other psychiatric disease by molecular hybridization using cloned DNA. J Neuropathol Exp Neurol. 1985 Mar;44(2):176–184. doi: 10.1097/00005072-198503000-00006. [DOI] [PubMed] [Google Scholar]
  136. Taylor G. R., Crow T. J. Viruses in human brains: a search for cytomegalovirus and herpes virus 1 DNA in necropsy tissue from normal and neuropsychiatric cases. Psychol Med. 1986 May;16(2):289–295. doi: 10.1017/s0033291700009107. [DOI] [PubMed] [Google Scholar]
  137. Taylor G. R., Roberts G. W., Crow T. J., Royds J. A., Gamble S. J., Taylor C. B., Carter G. I., Timperley W. R. The cytopathogenic agent in CSF: evidence for a relationship with enolase levels. J Neurol Neurosurg Psychiatry. 1985 Mar;48(3):281–281. doi: 10.1136/jnnp.48.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Toorey E. F., Peterson M. R., Brannon W. L., Carpenter W. T., Post R. M., Van Kammen D. P. Immunoglobulins and viral antibodies in psychiatric patients. Br J Psychiatry. 1978 Apr;132:342–348. doi: 10.1192/bjp.132.4.342. [DOI] [PubMed] [Google Scholar]
  139. Torrey E. F., Albrecht P., Behr D. E. Permeability of the blood-brain barrier in psychiatric patients. Am J Psychiatry. 1985 May;142(5):657–658. doi: 10.1176/ajp.142.5.657. [DOI] [PubMed] [Google Scholar]
  140. Torrey E. F. Are we overestimating the genetic contribution to schizophrenia? Schizophr Bull. 1992;18(2):159–170. doi: 10.1093/schbul/18.2.159. [DOI] [PubMed] [Google Scholar]
  141. Torrey E. F., Bowler A. E., Rawlings R., Terrazas A. Seasonality of schizophrenia and stillbirths. Schizophr Bull. 1993;19(3):557–562. doi: 10.1093/schbul/19.3.557. [DOI] [PubMed] [Google Scholar]
  142. Torrey E. F., Bowler A. Geographical distribution of insanity in America: evidence for an urban factor. Schizophr Bull. 1990;16(4):591–604. doi: 10.1093/schbul/16.4.591. [DOI] [PubMed] [Google Scholar]
  143. Torrey E. F., McGuire M., O'Hare A., Walsh D., Spellman M. P. Endemic psychosis in western Ireland. Am J Psychiatry. 1984 Aug;141(8):966–970. doi: 10.1176/ajp.141.8.966. [DOI] [PubMed] [Google Scholar]
  144. Torrey E. F., Peterson M. R. Slow and latent viruses in schizophrenia. Lancet. 1973 Jul 7;2(7819):22–24. doi: 10.1016/s0140-6736(73)91952-1. [DOI] [PubMed] [Google Scholar]
  145. Torrey E. F. Prevalence studies in schizophrenia. Br J Psychiatry. 1987 May;150:598–608. doi: 10.1192/bjp.150.5.598. [DOI] [PubMed] [Google Scholar]
  146. Torrey E. F. Stalking the schizovirus. Schizophr Bull. 1988;14(2):223–229. doi: 10.1093/schbul/14.2.223. [DOI] [PubMed] [Google Scholar]
  147. Torrey E. F., Upshaw Y. D., Suddath R. Medication effect on lymphocyte morphology in schizophrenia. Schizophr Res. 1989 Jul-Oct;2(4-5):385–390. doi: 10.1016/0920-9964(89)90031-5. [DOI] [PubMed] [Google Scholar]
  148. Torrey E. F., Yolken R. H., Winfrey C. J. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science. 1982 May 21;216(4548):892–894. doi: 10.1126/science.6281883. [DOI] [PubMed] [Google Scholar]
  149. Tyrrell D. A., Parry R. P., Crow T. J., Johnstone E., Ferrier I. N. Possible virus in schizophrenia and some neurological disorders. Lancet. 1979 Apr 21;1(8121):839–841. doi: 10.1016/s0140-6736(79)91261-3. [DOI] [PubMed] [Google Scholar]
  150. Uchida T., Suzuki K., Hayashi N., Iida F., Hara T., Oo S. S., Wang C. K., Shikata T., Ichikawa M., Rikihisa T. Hepatitis E virus: cDNA cloning and expression. Microbiol Immunol. 1992;36(1):67–79. doi: 10.1111/j.1348-0421.1992.tb01643.x. [DOI] [PubMed] [Google Scholar]
  151. VANDER KAMP H. Nuclear changes in the white blood cells of patients with schizophrenic reaction. A preliminary report. J Neuropsychiatr. 1962 Sep-Oct;4:1–3. [PubMed] [Google Scholar]
  152. VAUGHAN W. T., Jr, SULLIVAN J. C., ELMADJIAN F. Immunity and schizophrenia; a survey of the ability of schizophrenic patients to develop an active immunity following the injection of pertussis vaccine. Psychosom Med. 1949 Nov-Dec;11(6):327–333. doi: 10.1097/00006842-194911000-00001. [DOI] [PubMed] [Google Scholar]
  153. Vartanian M. E., Kolyaskina G. I., Lozovsky D. V., Burbaeva G. S., Ignatov S. A. Aspects of humoral and cellular immunity in schizophrenia. Birth Defects Orig Artic Ser. 1978;14(5):339–364. [PubMed] [Google Scholar]
  154. Villemain F., Chatenoud L., Galinowski A., Homo-Delarche F., Ginestet D., Loo H., Zarifian E., Bach J. F. Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry. 1989 May;146(5):609–616. doi: 10.1176/ajp.146.5.609. [DOI] [PubMed] [Google Scholar]
  155. Viscidi R. P., Sun Y., Tsuzaki B., Bosch F. X., Muñoz N., Shah K. V. Serologic response in human papillomavirus-associated invasive cervical cancer. Int J Cancer. 1993 Nov 11;55(5):780–784. doi: 10.1002/ijc.2910550515. [DOI] [PubMed] [Google Scholar]
  156. Weinberger D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987 Jul;44(7):660–669. doi: 10.1001/archpsyc.1987.01800190080012. [DOI] [PubMed] [Google Scholar]
  157. Wessely S., Castle D., Der G., Murray R. Schizophrenia and Afro-Caribbeans. A case-control study. Br J Psychiatry. 1991 Dec;159:795–801. doi: 10.1192/bjp.159.6.795. [DOI] [PubMed] [Google Scholar]
  158. Wood K., Harwood J., Coppen A. Plasma immunoglobulins in depressed and lithium-treated patients. Br J Psychiatry. 1985 Nov;147:581–582. [PubMed] [Google Scholar]
  159. Woodall C. J., Riding M. H., Graham D. I., Clements G. B. Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease. BMJ. 1994 Jun 11;308(6943):1541–1543. doi: 10.1136/bmj.308.6943.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Wright H. T., Jr, Parker C. E., Mavalwala J. Unusual dermatoglyphic findings associated with cytomegalic inclusion disease of infancy. A first report and practical review. Calif Med. 1972 Mar;116(3):14–20. [PMC free article] [PubMed] [Google Scholar]
  161. Yolken R. H. Enzyme immunoassays for the detection of infectious antigens in body fluids: current limitations and future prospects. Rev Infect Dis. 1982 Jan-Feb;4(1):35–68. doi: 10.1093/clinids/4.1.35. [DOI] [PubMed] [Google Scholar]
  162. Yolken R. H., Stopa P. J. Analysis of nonspecific reactions in enzyme-linked immunosorbent assay testing for human rotavirus. J Clin Microbiol. 1979 Nov;10(5):703–707. doi: 10.1128/jcm.10.5.703-707.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Youssef H. A., Kinsella A., Waddington J. L. Evidence for geographical variations in the prevalence of schizophrenia in rural Ireland. Arch Gen Psychiatry. 1991 Mar;48(3):254–258. doi: 10.1001/archpsyc.1991.01810270066009. [DOI] [PubMed] [Google Scholar]
  164. el-Mallakh R. S., Suddath R. L., Wyatt R. J. Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry. 1993 May;17(3):383–391. doi: 10.1016/0278-5846(93)90072-z. [DOI] [PubMed] [Google Scholar]
  165. van Kammen D. P., Mann L., Scheinin M., van Kammen W. B., Linnoila M. Spinal fluid monoamine metabolites and anti-cytomegalovirus antibodies and brain scan evaluation in schizophrenia. Psychopharmacol Bull. 1984 Summer;20(3):519–522. [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES